• Clodronate Liposomes for In Vivo Macrophage Depletion: Proto

  2026-05-15

  Clodronate Liposomes unlock precise, tissue-specific macrophage depletion for studies of immune modulation, inflammation, and tissue injury. This guide translates newly published single-cell and polarization insights into actionable workflows, troubleshooting strategies, and advanced experimental applications.

• N6-Methyl-dATP: Precision Epigenetic Probe for Replication F

  2026-05-14

  N6-Methyl-dATP offers unique advantages for dissecting DNA replication fidelity and methylation-driven genomic stability. APExBIO’s high-purity reagent empowers robust experimental workflows in leukemia epigenetics, offering actionable troubleshooting paths and next-level data quality.

• Catalpol’s Multi-System Protective Actions: Beyond Neuroprot

  2026-05-14

  Explore Catalpol’s multifaceted mechanisms, from cardiovascular protection to advanced animal modeling. This article reveals how Catalpol enables cross-system translational research, with unique insights built on recent evidence.

• PBS Liposomes: Optimal Controls for Macrophage Depletion Ass

  2026-05-13

  PBS Liposomes set the gold standard for negative controls in macrophage depletion and phagocytosis assays, ensuring data credibility and workflow reproducibility. Discover how APExBIO’s phosphate-buffered saline liposomes streamline in vivo studies, resolve common protocol pain points, and enable precise evaluation of immune cell dynamics.

• Pam3CSK4 TFA: Precision TLR1/2 Agonist for Cytokine Profilin

  2026-05-13

  Pam3CSK4 TFA stands out as a high-purity, synthetic TLR1/2 agonist designed for robust activation of innate immune pathways in both in vitro and in vivo systems. Its use in cytokine profiling, especially for IL-17A as a predictive biomarker, enables translational workflows in maternal-neonatal immunity and inflammatory disease research.

• Capecitabine Applications in Tumor-Stroma Oncology Models

  2026-05-12

  Capecitabine enables precise modeling of tumor-targeted drug delivery and apoptosis induction in complex assembloid systems. This guide outlines optimized protocols, troubleshooting strategies, and advanced use-cases for leveraging Capecitabine in preclinical oncology research.

• Honokiol in Cancer Research: Workflow Optimization & Trouble

  2026-05-12

  Honokiol, a potent NF-κB pathway inhibitor and antiangiogenic compound, enables precision control of inflammation and oxidative stress in advanced cancer biology workflows. This article delivers actionable protocol enhancements, troubleshooting solutions, and comparative insights—translating recent in vitro drug response research into bench-ready best practices.

• Berberine Hydrochloride: Protocols for Metabolic & Inflammat

  2026-05-11

  Berberine Hydrochloride from APExBIO stands out as a versatile tool for metabolic disease and acute injury research, offering robust AMPK activation and inflammasome modulation. This guide details optimized workflows, advanced applications, and troubleshooting strategies to maximize experimental reproducibility in both cellular and in vivo models.

• Nile Red (Nile Blue Oxazone): Advanced Lipid Dynamics Analys

  2026-05-11

  Discover how Nile Red (Nile blue oxazone) empowers researchers to dissect intracellular lipid storage and metabolism with unmatched precision. This article explores advanced applications, assay design, and insights beyond standard protocols for lipid distribution imaging.

• HyperScript III RT SuperMix: Enabling Precision qPCR in CRC

  2026-05-10

  Discover how HyperScript III RT SuperMix advances gene expression analysis by qPCR, with an emphasis on high-fidelity reverse transcription and robust genomic DNA removal—a crucial leap for accurate colorectal cancer subtyping and biomarker validation.

• Mitochondrial TERC-53: A Noncoding RNA Signal Regulating Sen

  2026-05-09

  This study reveals that TERC, a telomerase RNA component, is processed by mitochondria into TERC-53, which then acts as a retrograde signal controlling cellular senescence and cognitive decline, independent of telomerase activity. The findings establish a new paradigm for noncoding RNA-mediated mitochondrial-nuclear communication in aging biology.

• SAG: Smoothened Receptor Agonist for Robust Hedgehog Assays

  2026-05-09

  SAG enables precise Hedgehog pathway activation in neuroregeneration, stem cell, and immune modulation research. This article details stepwise protocols, reference-backed troubleshooting, and unique insights from recent studies on sex-dependent immune effects. Leverage SAG’s reproducibility for advanced disease modeling with APExBIO’s trusted quality.

• Dissecting In Vitro Drug Response: Implications for PDK1 Inh

  2026-05-08

  This dissertation investigates how in vitro assays can more precisely distinguish between cancer cell growth inhibition and cell death in response to anti-cancer drugs, challenging the widespread conflation of these metrics. The findings offer a rigorous methodological framework for interpreting the multifaceted actions of kinase inhibitors, which directly impacts the evaluation of compounds like BX795.

• CCL7+ Macrophages Mediate Immunotherapy Resistance in CRC

  2026-05-07

  Chen et al. (2025) reveal that CCL7-expressing tumor-associated macrophages (TAMs) drive resistance to immune checkpoint inhibitors in colorectal cancer by modulating immune cell infiltration and metabolic programming. Their mechanistic dissection highlights CCL7 as a promising therapeutic target to enhance immunotherapy efficacy in CRC.

• Human iPSC Lines from Psychiatric Disorder Patients: A New M

  2026-05-07

  This study presents the generation and comprehensive characterization of human induced pluripotent stem cell (iPSC) lines derived from two cousins with schizophrenia and bipolar disorder and their unaffected cousin. These patient-specific iPSCs provide a valuable platform for investigating neurodevelopmental mechanisms and for future drug screening in psychiatric research.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page